Trial Profile
Pilot study of levosimendan-based therapy as inotropic support following heart transplant.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Acute heart failure
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 30 Nov 2015 New trial record